The Trump administration will allow small employers to use tax-free health reimbursement accounts (HRAs) to provide health coverage to workers; the number of fatal drug overdoses nationwide has fallen for 6 consecutive months; a pilot study with a small sample size of 8 people discovered that microplastics can make their way into the human gut.
The Trump administration will allow small employers to use tax-free health reimbursement accounts (HRAs) to provide health coverage to workers, the Associated Press reported. Under the plan, expected to be formally announced Tuesday, employees could buy their own individual health insurance policies. Health policy critics have said the approach will undermine traditional job-based coverage, and the Obama administration had discouraged the practice. HRAs join other health insurance changes, including association health plans and short-term policies.
The number of fatal drug overdoses nationwide has fallen for 6 consecutive months, reversing a sharp rise during the past few years, but public health experts warned against drawing firm conclusions based on a small timeframe, STAT News reported. In in the 12-month period ending in March 2018, the CDC reported a decline of 2.8% in the number of overdose deaths, to an estimated 71,073 people, compared with the 12 months ending in September 2017.
A pilot study with a small sample size of 8 people discovered that microplastics can make their way into the human gut, The New York Times reported. In a European study, researchers examined stool samples from volunteers in 8 countries and were surprised when every single sample tested positive for the presence of a variety of microplastics. Microplastics, about the size of a grain of rice, have become a major concern for environmental researchers over the past decade as plastic bags and bottles make their way into the ocean. The most common plastics detected were polypropylene and polyethylene terephthalate—both major components of plastic bottles and caps. The health effects are unknown and more research is needed.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More